Portfolio Company BitBio Recently Announced a Partnership with Automata portfolioDynamk CapitalFebruary 10, 2023
Portfolio Company Envisagenics enters into Multi-Year Collaboration with BMS portfolioDynamk CapitalNovember 29, 2022
Portfolio Co. Vectron Biosolutions Partners with Plant-Based Foods Manufacturer portfolioDynamk CapitalOctober 26, 2022
Portfolio Co. RoosterBio and AGC Biologics Announce Collaboration portfolioDynamk CapitalAugust 23, 2022
Dynamk Capital Co-Leads $21M Vernal Biosciences round along with Ampersand Capital Partners portfolioDynamk CapitalJune 2, 2022
Bionter AG secures $3 Million in Series Seed Financing Led by Dynamk Capital portfolioDynamk CapitalApril 27, 2022
Portfolio Company Xcellbio expands Labcorp Collaboration for Cell & Gene Therapies portfolioDynamk CapitalApril 21, 2022
Envisagenics Raises Series A Financing to Scale Its AI-powered RNA Splicing Drug Discovery Platform portfolioDynamk CapitalSeptember 29, 2021
Lightspeed Microscopy, Inc. raises $4M in Series A Financing Round with Plans to Revolutionize Pathology portfolioDynamk CapitalJune 15, 2021
Curi Bio Raises $6M Series A Financing Round for iPSC-derived Predictive Platforms portfolioDynamk CapitalMarch 18, 2021
CellFE Closes $4.8M Seed Round Funding Co-led by Dynamk Capital and Cota Capital portfolioDynamk CapitalMarch 31, 2020
CellFE Raises $3.6 Million in Series Seed Round Co-Led by Dynamk Capital and Cota Capital portfolioDynamk CapitalJanuary 16, 2020
RoosterBio Raises $15 Million in Series B Round Led by Dynamk Capital portfolioDynamk CapitalAugust 6, 2019
